Clinical trials · Seattle, WA
Psychosis Associated With Alzheimer's Disease clinical trials in Seattle
We’re tracking 5 recruiting psychosis associated with alzheimer's disease studies with a site in or near Seattle — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Seattle
- NCT06540833RecruitingPhase 2
Study of ITI-1284 for psychosis in Alzheimer's disease
This trial tests an experimental drug, ITI-1284, to see if it can safely reduce psychosis (hallucinations or delusions) in people with Alzheimer's disease. It may be an option for patients who have both Alzheimer's and related psychotic symptoms.
Bellevue, WashingtonAges 55 years+ - NCT06887192RecruitingPhase 2
Testing ML-007C-MA for Alzheimer's Psychosis
This trial tests a study drug called ML-007C-MA to see if it can safely reduce hallucinations and delusions in people with Alzheimer's disease who also have psychosis. If you or your loved one has Alzheimer's and has been experiencing false beliefs or seeing/hearing things that aren't there for at least two months, this study may be an option.
Bellevue, WashingtonAges 55–90 - NCT06585787RecruitingPhase 3
Testing KarXT for psychosis in Alzheimer’s disease
This study tests an investigational medication (KarXT) for treating psychosis—hallucinations or delusions—in people with Alzheimer’s disease. It aims to see if the drug can reduce these symptoms safely and effectively.
Bellevue, WashingtonAges 55–90 - NCT05980949RecruitingPhase 3
Long-term safety study of KarXT for Alzheimer's psychosis
This trial tests the long-term safety of an investigational drug called KarXT for people with psychosis caused by Alzheimer's disease. It is for those who have already completed a previous KarXT study and want to continue treatment.
Kirkland, WashingtonAges 55–90 - NCT06976203RecruitingPhase 3
Testing karxt for thinking problems in alzheimer's
This trial tests if a combination medicine, KarXT plus KarX-EC, can help with thinking and memory problems in people with mild to moderate Alzheimer's disease. It aims to see if the treatment is safe and effective.
Renton, WashingtonAges 60–85
Hear when a new Psychosis Associated With Alzheimer's Disease trial opens near Seattle, WA
We’ll email you when one opens near Seattle, WA — at most once a week, no account needed, unsubscribe anytime.
Psychosis Associated With Alzheimer's Disease trials in other cities
Where these studies are running near Seattle
Institutions with a site for the recruiting psychosis associated with alzheimer's disease studies listed above.
- Local Institution - 1254 · 2 studies
- Northwest Clinical Research Center · 2 studies
- Clinical Site
- Local Institution - 0076
What taking part in a psychosis associated with alzheimer's disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting psychosis associated with alzheimer's disease studies in Washington.
Common questions
- Are there psychosis associated with alzheimer's disease clinical trials near Seattle?
- Yes. We're currently tracking 5 recruiting psychosis associated with alzheimer's disease studies with a site near Seattle, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a psychosis associated with alzheimer's disease study near Seattle?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Seattle to take part?
- Not necessarily. These studies have a site near Seattle, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a psychosis associated with alzheimer's disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New psychosis associated with alzheimer's disease studies open near Seattle regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.